Komori
Revision of earnings forecasts4367KOEI CHEMICAL COMPANY,LIMITEDMaterials and Chemicals

Notice Regarding Revisions to the Earnings Forecast for the Fiscal Year Ending March 2026

For the full-year forecast for the fiscal year ending March 2026, the sales forecast remains unchanged at ¥17,000 million, while the operating profit forecast has been raised to ¥360 million and the ordinary profit forecast to ¥250 million. Net income is still expected to be negative, but the net loss is expected to narrow from ¥5,400 million to ¥5,140 million.

Worth reading
62In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
150
%
Wording
Avoiding a definitive answer
How definitive the wording is.

Revised forecast

Fiscal year ending March 2026 · Full yearPrevious forecast published Announced on 31 March 2026
Net Sales17,000→17,000million yen
0.0%
Operating profit200→360million yen
+80.0%
Ordinary income100→250million yen
+150.0%
Profit attributable to owners of the parent-5,400→-5,140million yen
+4.8%
Net income per share-1,104.06→-1,050.91yen and sen
+4.8%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

Multiple factors are expected to increase profit, including the smoother-than-expected completion of production of certain products following scheduled maintenance, a decline in fixed costs as the results of cost-cutting efforts exceeded expectations, and a greater-than-expected increase in the fiscal year-end market value of inventories with market prices. In addition, the amount of impairment loss recognized is expected to decrease as a result of more precise impairment accounting calculations.

Details and amount of extraordinary loss

The amount of impairment loss recognized is expected to decrease. No specific amount is stated.

Previous-period resultsFiscal year ended March 2025: sales of ¥20,018 million, operating profit of ¥566 million, ordinary profit of ¥356 million, net income of ¥288 million, and net income per share of ¥58.96
Dividend forecast revisionNo change (year-end dividend of ¥50 per share)
Revised forecast
ItemDetails
Net Sales17,000 million yen → 17,000 million yen(0.0%)
Operating profit200 million yen → 360 million yen(+80.0%)
Ordinary income100 million yen → 250 million yen(+150.0%)
Profit attributable to owners of the parent-5,400 million yen → -5,140 million yen
Net income per share-1,104.06 yen and sen → -1,050.91 yen and sen
Fiscal Period CoveredFiscal year ending March 2026
Period CoveredFull year
Publication date of previous forecastAnnounced on 31 March 2026
Previous-period resultsFiscal year ended March 2025: sales of ¥20,018 million, operating profit of ¥566 million, ordinary profit of ¥356 million, net income of ¥288 million, and net income per share of ¥58.96
Reason for the revisionMultiple factors are expected to increase profit, including the smoother-than-expected completion of production of certain products following scheduled maintenance, a decline in fixed costs as the results of cost-cutting efforts exceeded expectations, and a greater-than-expected increase in the fiscal year-end market value of inventories with market prices. In addition, the amount of impairment loss recognized is expected to decrease as a result of more precise impairment accounting calculations.
Details and amount of extraordinary lossThe amount of impairment loss recognized is expected to decrease. No specific amount is stated.
Dividend forecast revisionNo change (year-end dividend of ¥50 per share)
Items this document does not state (1)
Consolidated / non-consolidated

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Production of certain products following scheduled maintenance was completed more smoothly than expected, fixed costs declined as a result of cost-cutting efforts, the fiscal year-end market value of inventories with market prices increased more than expected, and the amount of impairment loss recognized is expected to decrease as a result of more precise impairment accounting calculations, among other factors.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Revisions to the Earnings Forecast for the Fiscal Year Ending March 2026 | KOEI CHEMICAL COMPANY,LIMITED (4367) timely disclosure | Komori